Angiosomal radiopathologic analysis of transarterial radioembolization for the treatment of hepatocellular carcinoma.
Altan F AhmedNaziya SamreenJoseph R GrajoIvan ZendejasChris L SistromAmy CollinsworthAshwini EsnakulaJehan L ShahRoniel CabreraBrian S GellerBeau B ToskichPublished in: Abdominal radiology (New York) (2019)
The absence of hepatocyte-specific contrast uptake, increased signal on T2-weighted sequences, and plateau or persistent enhancement in the angiosome may represent MRI surrogates of CPN following TARE of HCC. These findings correlated with EASL and mRECIST response criteria. Further investigation is needed to determine the role of these findings as possible adjuncts to conventional imaging criteria.